VITAE PHARMACEUTICALS INC |
Precio de cierre
Otros sitios de cotización
|
||
| - USD | - |
|
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Ambrose Bailey
PSD | President | 60 | 25/10/16 |
Carole A. Sable
CTO | Chief Tech/Sci/R&D Officer | 62 | 06/06/16 |
John Grosso
BRD | Director/Board Member | - | - |
Kira M. Schwartz
SEC | Corporate Secretary | - | 25/10/16 |
| Treasurer | - | 25/10/16 | |
| Corporate Officer/Principal | - | 01/01/02 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
John Grosso
BRD | Director/Board Member | - | - |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 28 841 278 | 28 327 732 ( 98,22 %) | 211 ( 0,000732 %) | 98,22 % |
Información de la empresa
Vitae Pharmaceuticals LLC
502 West Office Center Drive
19034, Fort Washington
+215-461-2000
http://www.vitaepharma.com
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +1,45 % | 40,51 mil M | |
| -15,94 % | 31,67 mil M | |
| +52,66 % | 24,62 mil M | |
| -14,50 % | 15,65 mil M | |
| -14,38 % | 12,07 mil M | |
| -9,12 % | 11,97 mil M | |
| -42,56 % | 11,61 mil M | |
| +4,87 % | 8810,05 M | |
| -4,33 % | 8495,99 M |
- Bolsa de valores
- Acciones
- Acción
- Empresa Vitae Pharmaceuticals Inc
